Rhumbline Advisers cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent ...
As promised, the restructuring initiatives taking place at Charles River Labs (NYSE: CRL) have resulted in a reduced ...
Q4 2024 Earnings Call Transcript February 19, 2025 Charles River Laboratories International, Inc. beats earnings expectations ...
Barclays lowered the firm’s price target on Charles River (CRL) to $160 from $166 and keeps an Equal Weight rating on the shares post the Q4 ...
Charles River's Q4 revenue topped estimates despite a 1.1% decline. The company forecasts a revenue drop in 2025, with biotech demand expected to stabilize.
Charles River Laboratories International, Inc. CRL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, ...
Charles River Laboratories International Inc. (CRL) on Wednesday reported a loss of $215.7 million in its fourth quarter. The ...
New York State Teachers Retirement System decreased its holdings in shares of Charles River Laboratories International, Inc. ...
Analysts have set 12-month price targets for Charles River, revealing an average target of $185.0, a high estimate of $210.00 ...
Analysts fell to the sidelines weighing in on DaVita (DVA – Research Report) and Charles River Labs (CRL – Research Report) with neutral ...
Predatory lending is rampant in low-income communities, draining over $2.4 billion from cash-strapped borrowers. Protect your finances and support responsible lending policies.